XM tidak menyediakan perkhidmatan kepada penduduk Amerika Syarikat.

Wall St slips as Fed's first rate cut in four years looms



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Wall St slips as Fed's first rate cut in four years looms</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.

Fed rate decision due at 2:00 p.m. ET

Intuitive Machines soars after clinching NASA contract

Indexes down: Dow 0.24%, S&P 500 0.27%, Nasdaq 0.39%

Updated at 12:04 p.m. ET/1604 GMT

By Johann M Cherian and Purvi Agarwal

Sept 18 (Reuters) -Wall Street's main indexes slipped in volatile trading onWednesday ahead of theFederal Reserve's highly anticipatedfirst interest rate cut in more than four years, with jitters over the magnitude of the reduction dominating mood.

Borrowing costs have stayed at their highest levels in over two decades since July 2023, when the central bank last hiked interest rates by 25 basis points to between 5.25% and 5.50% to combat inflation. But the focus recently has moved toa moderating labor market.

At 12:04 p.m., the Dow Jones Industrial Average .DJI fell 101.36 points, or 0.24%, to 41,504.82, the S&P 500 .SPX lost 15.32 points, or 0.27%, to 5,619.26 and the Nasdaq Composite .IXIC lost 68.11 points, or 0.39%, to 17,559.95.

Eight of the 11 S&P 500 sectors slipped, although healthcare .SPXHC edged up 0.1%.

The Russell 2000 index .RUT, tracking small caps, also dipped 0.2%, while the CBOE Volatility index .VIX hit a one-week high and was last up 1.53 points at 19.14.

Still, thebenchmark S&P 500 .SPX and the blue-chip Dow .DJI are trading just shy of their respective record highs aheadof the Fed decision, expected at 2:00 p.m. ET.

Mixed economicindicators over the previous one month have made investors nervous aheadof the least-predictable Fed decision in years.

However,dovish commentary from present and former Fed officials recently have ledtraders to price in 53% chances of a bigger 50-basis-point reduction, according to the CME Group's FedWatch tool.

Still, few analysts caution that an outsized move from the central bank could spook markets as it would be more inconsistent with how the Fed has begun prior easing cycles outside of any brewing crisis.

Bets for a smaller 25-bps cut now stand at47% compared with 36% a dayago. Comments from Fed Chair Jerome Powell at 2:30 p.m. ET will be on the radar forthe central bank's stance on the economy and prospects of further rate cuts this year.

If the Fed cuts by 50 bps instead of 25 bps, it will skip reducing rates next month, said Erica Groshen, senior economics adviser at Cornell University, adding that if it is the other way round, the central bank will lift its "foot off more rapidly" next month.

"Fortunately, things don't seem to be in a high degree of flux like they were during the financial crisis or during COVID when rapid movements were necessary to avoid disaster."

Stock options are pricing a 1.1% swing, in either direction, for the S&P 500 after the Fed's verdict, according to options analytics service ORATS.

Markets have rallied this year, with all three major indexes setting record highs on prospects of lower interest rates as inflation moderated and the jobs market showed gradual signs of cooling.



Heavyweight growth stocks such asApple AAPL.Oclimbed 1.4%, while Alphabet GOOGL.O dipped 0.29% and Microsoft MSFT.O lost 1%. Treasury yields across the board inched higher. US/

Intuitive Machines LUNR.O jumped 56% after clinching a $4.8 billion navigation services contract from NASA.

Declining issues outnumbered advancers by a 1.52-to-1 ratio on the NYSE and by a 1.61-to-1 ratio on the Nasdaq.

The S&P 500 posted 18 new 52-week highs and no new lows, while the Nasdaq Composite recorded 55 new highs and 44 new lows.


Index performance over the past year https://reut.rs/47sKowp


Reporting by Purvi Agarwal and Johann M Cherian in Bengaluru; Editing by Pooja Desai and Maju Samuel

</body></html>

Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.

Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.

Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.

Amaran Risiko: Modal anda dalam risiko. Produk yang berleveraj mungkin tidak sesuai untuk semua individu. Sila pertimbangkan Pendedahan Risiko kami.